Practical Approaches to Diabetes Care: An Introduction Marc EvansAbigail Maisey PRACTICAL APPROACH Open access 18 July 2016 Pages: 377 - 377
A Practical Approach to Gastrointestinal Complications of Diabetes Abigail Maisey PRACTICAL APPROACH Open access 18 July 2016 Pages: 379 - 386
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus Margaret BannisterJenny Berlanga Commentary Open access 08 August 2016 Pages: 387 - 399
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Sandro GentileFelice StrolloOn behalf of the AMD-OSDI Injection Technique Study Group Review Open access 25 July 2016 Pages: 401 - 409
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review Amrita OstawalEmina MocevicWeiwei Xu Review Open access 27 June 2016 Pages: 411 - 438
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment Merlin C. ThomasPäivi M. PaldániusPer-Henrik Groop Review Open access 08 August 2016 Pages: 439 - 454
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes Kyle T. BaronSreeraj MachaMatthew Riggs Original Research Open access 16 June 2016 Pages: 455 - 471
Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care Brian LeeDace TrenceTerry Dex Original Research Open access 06 June 2016 Pages: 473 - 481
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records Wlodzimierz M. KolaczynskiMatthew HankinsMassoud Toussi Original Research Open access 04 June 2016 Pages: 483 - 496
How Much Time Do Families Spend on the Health Care of Children with Diabetes? Jane E. MillerColleen N. NugentLouise B. Russell Original Research Open access 27 June 2016 Pages: 497 - 509
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers William GreenMatthew Taylor Original Research Open access 11 July 2016 Pages: 511 - 525
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment Shira PerlWilliam CookBoaz Hirshberg Original Research Open access 11 July 2016 Pages: 527 - 535
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study Ronan RousselBernard CharbonnelBruno Detournay Original Research Open access 15 July 2016 Pages: 537 - 549
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study Mohamed KhattabKhalifa MahmoudInass Shaltout Original Research Open access 22 August 2016 Pages: 551 - 560
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study Vincent LakAnn-Marie SvenssonBjörn Eliasson Original Research Open access 12 August 2016 Pages: 561 - 573
Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes Gregory C. JonesZhou M. ChongChristopher A. R. Sainsbury Original Research Open access 22 August 2016 Pages: 575 - 582
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis Bo AhrénGagik GalstyanHernando Vargas-Uricoechea Brief Report Open access 18 June 2016 Pages: 583 - 590
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective Alla K. OvsyannikovaOksana D. RymarMikhail I. Voevoda Case Report Open access 18 August 2016 Pages: 591 - 600
